Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Statistical Reasoning in Law and Public Policy: Tort Law, Evidence and Health
    Statistical Reasoning in Law and Public Policy: Tort Law, Evidence and Health
    Statistical Reasoning in Law and Public Policy: Tort Law, Evidence and Health
    Ebook440 pages11 hours

    Statistical Reasoning in Law and Public Policy: Tort Law, Evidence and Health

    By Joseph L. Gastwirth

    ()

    Read preview

    About this ebook

    To reach reasoned decisions involving issues of public policy and law, statistical data and studies often need to be assessed for their accuracy and relevance. This two-volume set presents a unique and comprehensive treatment of statistical methods in legal practice. Designed to serve as a text or reference, the book presents basic concepts of probability and statistical inference applied to actual data arising from court cases concerning discrimination, trademark evidence, environmental and occupational exposure to toxic chemicals, and related health and safety topics. Substantial attention is devoted to assessing the strengths and weaknesses of statistical studies, with examples illustrating why some health studies may not have been properly designed at the outset and how actual decisions might have been reversed had more appropriate analysis of data been available to the court. This book will be of interest to lawyers and other practitioners of the law, as well as to students and researchers in the areas of statistics, statistical economics, political science, and law.
    LanguageEnglish
    PublisherAcademic Press
    Release dateNov 28, 1988
    ISBN9780323138727
    Statistical Reasoning in Law and Public Policy: Tort Law, Evidence and Health

    Related to Statistical Reasoning in Law and Public Policy

    Titles in the series (8)

    View More
    View More

    Related ebooks

    Mathematics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      The Parties Understand and Agree That by Entering Into This Agreement They Are Each Relinquishing and Waiving Their Right Under Applicable Law to Have Any Claim Decided in a Court of Law Before a Judge and/or Jury.

      Nov 27, 2017

      I. SISTER IRENE MORISSETTE ALWAYS LOCKED HER DOOR AT night. Maybe it was force of habit from her decades teaching at an isolated missionary school in Africa, or maybe it was, as she told a police detective later, just that she didn’t want “anyone co

      11 min read

    • Article

      Why I Hate Monte Carlo Analysis and Other Financial Projections

      Aug 14, 2019

      I'm not a fan of financial plans that use straight-line projections or Monte Carlo risk analysis to support investment proposals. Here's why: They can lull people into a false sense of security or lead them to believe that the stock market is the ans

      5 min read

    • Article

      Opening The ‘Black Box,’ Google DeepMind AI System Diagnoses Eye Diseases And Shows Its Work

      Aug 13, 2018

      Experts said the level of accuracy is impressive, but the bigger breakthrough is the DeepMind system’s solution to the so-called “black box” problem of artificial intelligence.

      5 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      Opinion: Sharing Clinical Trial Data: Lessons From The YODA Project

      Nov 18, 2019

      The culture of clinical research is changing, and there are now expectations that researchers will share data — even when it isn't required.

      5 min read

    • Article

      What Patients Think Of Companies Selling Their DNA

      Sep 18, 2018

      A new survey reveals public attitudes toward potential commercial use of their DNA, blood, and tissue samples. Recently, the almost 5 million people who paid to have 23andMe analyze their DNA found out that the company might have sold their genetic d

      2 min read

    • Article

      Blood Test May Flag Shaken Baby Syndrome

      Apr 11, 2017

      Scientists have developed and refined a blood test that could help clinicians identify infants who may have had bleeding of the brain as a result of abusive head trauma, sometimes referred to as shaken baby syndrome. The serum-based test, which needs

      2 min read

    • Article

      Can Roche’s Little Tech Startup Help The FDA Change Clinical Trials?

      Feb 25, 2019

      A startup founded by two guys in their 20s turned into a $1.9 billion acquisition — and now is increasingly catching the interest of the FDA.

      4 min read

    • Article

      Opinion: Oncologists Are Guardedly Optimistic About AI. But Will It Drive Real Improvements In Cancer Care?

      Jul 3, 2019

      Unless developers of artificial intelligence applications understand what doctors want and need, AI will become just another here today, gone tomorrow health care technology story.

      3 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      To Improve Business, Have Computers Judge Experts’ Work

      Aug 25, 2017

      New research suggests that combining human intuition and the impartiality of computers could improve decision-making in businesses and organizations, lowering costs and increasing profits. “Everybody likes to claim that they are experts, yet deep dow

      3 min read

    • Article

      Is Transparency Always A Good Thing? EPA Weighs Controversial New Rule.

      Mar 12, 2020

      The Environmental Protection Agency is mulling a proposal to give preference to scientific research whose datasets and models are publicly available.

      3 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      DeepMind AI Predicts Acute Loss Of Kidney Function Two Days In Advance, Study Shows

      Jul 31, 2019

      DeepMind's AI was able to predict 90% of acute kidney injury episodes that required dialysis, with a lead time of 48 hours.

      2 min read

    • Article

      FDA And NIH Let Clinical Trial Sponsors Keep Results Secret, Investigation Shows

      Jan 14, 2020

      A Science investigation shows that many clinical trial sponsors still ignore the requirement to report results, while federal officials do little to enforce the law.

      5 min read

    • Article

      National Academies Panel Urges Researchers To Routinely Share Test Results With Study Participants

      Jul 10, 2018

      "It's really calling for a sea change," said the author of a new National Academies report urging the routine release of test results to participants in human research.

      3 min read

    Related categories

    Reviews for Statistical Reasoning in Law and Public Policy

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Statistical Reasoning in Law and Public Policy - Joseph L. Gastwirth

      Enjoying the preview?
      Page 1 of 1